Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Ther Adv Respir Dis ; 16: 17534666221110346, 2022.
Article in English | MEDLINE | ID: mdl-35796535

ABSTRACT

BACKGROUND: Recently, the SARS-CoV-2 variant of concern, Omicron (B.1.1.529), was identified as responsible for a novel wave of COVID-19 worldwide. Here, we compared initial clinical features of hospitalized COVID-19 patients during recent wave (Omicron Variant) with those in ancestral variant wave (2020). METHODS: This is a cohort study of electronic health record (EHR) data from a signal center in the China. The clinical data of 116 cases of Omicron hospitalized in 2022 and 87 cases hospitalized in 2020 were collected. The comparisons were performed with the Mann-Whitney U test, Fisher exact test or the chi-square test, and multivariable logistic regression analysis. RESULTS: Clinically, compared with 2020-cohort, Omicron-cohort was more inclined to cluster in younger population and had more nonsymptomatic (25.0%) and nonsevere cases, as well as suffered from comparable extrapulmonary complication. Radiologically, although the major computed tomography (CT) findings of both cohorts were ground-glass opacities (GGOs), crazy-paving pattern was relatively less seen in the Omicron-cohort. Based on multiple logistic regression analysis, Omicron-cohort was associated with a lower risk of complaining with fever, the presence of lung opacity, and increased Sequential Organ Failure Assessment (SOFA) score. CONCLUSION: This study provided the data of different patterns of clinic characteristics and reduced severity from infections that occurred in Omicron variant as compared with the outbreak of the epidemic in 2020 wave (ancestral variant).


Subject(s)
COVID-19 , SARS-CoV-2 , Cohort Studies , Humans , Tomography, X-Ray Computed/methods
2.
Kaohsiung J Med Sci ; 35(4): 222-229, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30958641

ABSTRACT

Research on anticervical cancer is urgently required to enhance clinical outcomes. As a main anticancer drug for cervical carcinoma, cisplatin (CIS) has been used for a lot of years in clinical therapy. However, serious adverse effects including nephrotoxicity and neurotoxicity limit its long-term treatment. Our main goal of this study is to investigate the improvement of Ganoderma lucidum polysaccharides (GPS) on CIS-induced antitumor effect of in U14 cervical carcinoma-bearing mice. The results showed that GPS + CIS could not only inhibit the growth of the tumor but also improve the spleen and thymus indexes. Moreover, little toxicological effects were observed on hepatic function and renal function in GPS + CIS treated mice bearing U14 tumor cells. Further analysis of the tumor inhibition mechanism indicated that the number of apoptotic tumor cells increased significantly, the expression of Bax increased and the expression of Bcl-2 decreased dramatically in cervical cancer sections after oral administration of GPS + CIS for 14 days. This GPS/CIS combined therapy represents intriguing therapeutic strategy for U14 cervical carcinoma providing not only superior efficacy but also a higher safety level.


Subject(s)
Antineoplastic Agents/therapeutic use , Cisplatin/therapeutic use , Polysaccharides/therapeutic use , Reishi/chemistry , Uterine Cervical Neoplasms/drug therapy , Alanine Transaminase/blood , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Aspartate Aminotransferases/blood , Blood Urea Nitrogen , Cell Line, Tumor , Cell Proliferation/drug effects , Cisplatin/pharmacology , Creatinine/blood , Female , Leukocyte Count , Mice , Polysaccharides/pharmacology , Survival Analysis , T-Lymphocyte Subsets/drug effects , T-Lymphocyte Subsets/immunology , Uterine Cervical Neoplasms/blood , Uterine Cervical Neoplasms/immunology , Uterine Cervical Neoplasms/pathology , bcl-2-Associated X Protein/metabolism
3.
Journal of Preventive Medicine ; (12): 328-333, 2015.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-792390

ABSTRACT

Objective To understand the influencing factors of pregnant women's choice of abortion methods by exhaustive CHAID decision tree and logistic regression model,and to evaluate the two statistical methods.Methods Pregnant women who underwent artificial abortion in 2011 were selected from 30 medical institutions of 10 cities in Zhejiang province.And a questionnaire survey was conducted.The influencing factors of pregnant women's choice of abortion methods were analyzed by exhaustive CHAID decision tree and logistic regression model,and the two methods were compared.Results Exhaustive CHAID tree analysis showed that the choice of artificial abortion methods were associated with preferences,gestational age, induced abortion history,marital status,fertility condition and abortion cognitive such as slight pain in drug abortion,the time limitation of drug abortion,greater possibility of curettage after induced abortion.Preferences and gestational age were the two major influencing factors.The model was stable and well fitting with the risk estimation 0.119 and prediction error 11.90%.And the logistic regression analysis showed the similar results expect induced abortion history and marital status. Age,education level and decision source were also the influencing factors in the logistic regression model.Conclusion The combination of decision tree and logistic regression analysis can analysis the influencing factors of pregnant women's choice of abortion methods,and information from the two methods should be combined to improve the efficiency of analysis.

4.
Zhongguo Gu Shang ; 22(9): 697-9, 2009 Sep.
Article in Chinese | MEDLINE | ID: mdl-19817207

ABSTRACT

OBJECTIVE: To observe the diagnosis and treatment of bone marrow edema syndrome and summarize its features, mechanisms and its differences from avascular necrosis of femoral head. METHODS: From 2004.1, 19 patients (12 patients were males and 7 patients were females, with a mean age of (46.70 +/- 10.36) years) with bone marrow edema syndrome of hip treated with Ibandronate and physical therapy, as well as scored with Harris system before and after treatment. RESULTS: Average score before treatment was (43.17 +/- 12.62), and (86.73 +/- 14.29) after treatment, and the difference was significant (P < 0.05). CONCLUSION: Bone marrow edema syndrome of hip is different from avascular necrosis of the hip, it is a distinct clinical entity.


Subject(s)
Bone Marrow Diseases/diagnosis , Bone Marrow Diseases/drug therapy , Femur Head Necrosis/diagnosis , Hip Joint/pathology , Adult , Bone Density Conservation Agents/therapeutic use , Bone Marrow Diseases/pathology , Bone Marrow Diseases/therapy , Diphosphonates/therapeutic use , Female , Femur Head Necrosis/pathology , Hip Joint/drug effects , Humans , Ibandronic Acid , Male , Middle Aged
5.
Chin J Integr Med ; 13(2): 98-102, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17609906

ABSTRACT

OBJECTIVE: To observe the clinical effect of Astragalus Injection (, AI) and its immuno-regulatory action in treating chronic aplastic anemia (CAA). METHODS: Sixty patients with CAA were randomly assigned to two groups equally, both were treated with Stanozolol three times a day, 2 mg each time through oral intake, but AI was given additionally to the patients in the treated group once a day via intravenous dripping. All were treated for 15 days as one therapeutic course and the whole medication lasted for more than 4 months totally, with follow-up adopted. The clinical efficacy was estimated and the changes of T-lymphocyte subsets in peripheral blood as well as the serum levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 (IL-2) were observed. RESULTS: The total effective rate in the treated group was 83.3% (25/30), which was higher than that in the control group 66.7% (20/30), showing significant difference between them (P<0.05). Levels of hemoglobin, WBC, reticular cell and platelet were elevated in both groups after treatment, but the improvement was significantly better in the treated group than that in the control group with respect to the former three indexes (P<0.05). The level of CD4(+) increased and that of CD8(+) decreased significantly after treatment in the treated group (P<0.05), which showed significant difference as compared with those in the control group (P<0.05). Levels of serum TNF-alpha and IL-2 lowered after treatment in both groups, but significance only showed in the treated group (P<0.05). The degree of proliferation in bone marrow got raised significantly and the percentage of non-hemopoietic cells reduced significantly in the treated group after treatment, also showing significant difference to those in the control group (P<0.05). CONCLUSION: AI could promote the recovery of hemopoietic function, which might be through improving T-lymphocyte subsets and reducing the release of negative regulatory factors such as TNF-alpha and IL-2 to alleviate the inhibition on hemopoietic function.


Subject(s)
Anemia, Aplastic/drug therapy , Astragalus Plant , Drugs, Chinese Herbal/therapeutic use , Anemia, Aplastic/blood , Anemia, Aplastic/immunology , Bone Marrow/drug effects , Chronic Disease , Follow-Up Studies , Humans , Injections , Interleukin-2/blood , Tumor Necrosis Factor-alpha/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...